Brief: Tianjin Development Says 9-Mth Net Profit Attributable For Tianjin Lisheng Pharmaceutical RMB112.6 Mln
27/10/2022 24:39
Oct 27 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* 9-MONTH TOTAL OPERATING INCOME OF TIANJIN LISHENG
PHARMACEUTICAL
RMB902MLN VERSUS RMB835.7 MILLION
* 9-MONTH NET PROFIT ATTRIBUTABLE FOR TIANJIN LISHENG
PHARMACEUTICAL RMB112.6 MILLION VERSUS RMB97.7 MILLION
Source text for Eikon: ID:nHKS62BFb4
Further company coverage: 0882.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln